Medicover AB Statistics

Total Valuation

Medicover AB has a market cap or net worth of GBP 2.25 billion. The enterprise value is 3.16 billion.

Market Cap	2.25B
Enterprise Value	3.16B

Important Dates

The next estimated earnings date is Wednesday, February 12, 2025.

Earnings Date	Feb 12, 2025
Ex-Dividend Date	Apr 29, 2024

Share Statistics

Current Share Class	n/a
Shares Outstanding	n/a
Shares Change (YoY)	+0.40%
Shares Change (QoQ)	n/a
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	50.26M

Valuation Ratios

The trailing PE ratio is 137.04.

PE Ratio	137.04
Forward PE	n/a
PS Ratio	n/a
PB Ratio	n/a
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 13.40, with an EV/FCF ratio of 31.13.

EV / Earnings	192.76
EV / Sales	1.90
EV / EBITDA	13.40
EV / EBIT	45.50
EV / FCF	31.13

Financial Position

The company has a current ratio of 0.75, with a Debt / Equity ratio of 2.17.

Current Ratio	0.75
Quick Ratio	0.63
Debt / Equity	2.17
Debt / EBITDA	4.05
Debt / FCF	9.38
Interest Coverage	1.43

Financial Efficiency

Return on equity (ROE) is 3.08% and return on invested capital (ROIC) is 3.31%.

Return on Equity (ROE)	3.08%
Return on Assets (ROA)	2.65%
Return on Capital (ROIC)	3.31%
Revenue Per Employee	36,945
Profits Per Employee	364
Employee Count	45,316
Asset Turnover	1.02
Inventory Turnover	26.14

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +24.82% in the last 52 weeks. The beta is 1.46, so Medicover AB's price volatility has been higher than the market average.

Beta (5Y)	1.46
52-Week Price Change	+24.82%
50-Day Moving Average	185.94
200-Day Moving Average	183.85
Relative Strength Index (RSI)	66.10
Average Volume (20 Days)	1,159

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Medicover AB had revenue of GBP 1.66 billion and earned 16.39 million in profits. Earnings per share was 0.11.

Revenue	1.66B
Gross Profit	344.17M
Operating Income	69.32M
Pretax Income	16.73M
Net Income	16.39M
EBITDA	166.01M
EBIT	69.32M
Earnings Per Share (EPS)	0.11

Full Income Statement

Balance Sheet

The company has 64.24 million in cash and 952.22 million in debt, giving a net cash position of -887.98 million.

Cash & Cash Equivalents	64.24M
Total Debt	952.22M
Net Cash	-887.98M
Net Cash Per Share	n/a
Equity (Book Value)	438.87M
Book Value Per Share	2.77
Working Capital	-118.16M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 199.88 million and capital expenditures -98.36 million, giving a free cash flow of 101.52 million.

Operating Cash Flow	199.88M
Capital Expenditures	-98.36M
Free Cash Flow	101.52M
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross margin is 20.70%, with operating and profit margins of 4.17% and 0.99%.

Gross Margin	20.70%
Operating Margin	4.17%
Pretax Margin	1.01%
Profit Margin	0.99%
EBITDA Margin	9.99%
EBIT Margin	4.17%
FCF Margin	6.11%

Dividends & Yields

Medicover AB does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	-3.01%
Years of Dividend Growth	n/a
Payout Ratio	91.37%
Buyback Yield	-0.40%
Shareholder Yield	-0.40%
Earnings Yield	0.73%
FCF Yield	4.52%

Dividend Details

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Medicover AB has an Altman Z-Score of 1.95. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	1.95
Piotroski F-Score	n/a